APMA members Rachel Albright, DPM, MPH; Patrick DeHeer, DPM; and Dyane Tower, DPM, MPH, MS, CAE, recently authored a letter to the editor to Foot and Ankle International addressing methodological concerns and limitations in an article comparing podiatry and orthopaedics.
The US House of Representatives passed HR 1, One Big Beautiful Bill, last Thursday, impacting Medicare, Medicaid, and other APMA Advocacy priorities. APMA continues to advocate for policies that are in the best interests of its members and their patients.
APMA expressed its serious concerns to Optum regarding its classification of podiatrists as Allied Health Professionals (AHPs) with doctorates under the Optum Partnership Program. Take action with APMA's template letter.
In support of Nevada podiatrists, APMA recently submitted a letter to the Nevada State Senate, supporting a legislative proposal that would ensure the Nevada State Board of Podiatry remains separate and independent from other boards.
APMA is urging the Trump administration to rescind or revise unsound policies that impede patient access to care and increase administrative burdens for podiatrists related to DME and the Medicare Therapeutic Shoes for Diabetics program.
APMA has new, on-demand virtual learning opportunities available. The courses include surgical complications and DEA MATE training.
APMA and 42 other state and national podiatric medical societies have submitted a co-signed letter to the House Committee on Energy and Commerce and the Senate Committee on Finance, urging these committees to protect and preserve access to care by podiatrists for Medicare and Medicaid beneficiaries in the forthcoming budget reconciliation process.
APMA representatives participated in the CPT® Editorial Panel meeting May 1-3 in Brooklyn, NY. The CPT® Editorial Panel ensures that CPT® codes reflect the latest medical care available to patients.
APMA representatives participated in the AMA/Specialty Society RVS Update Committee (RUC) meeting April 23–26 in Chicago. APMA is the only organization representing podiatry in the AMA RUC process.
All seven Part B Medicare Contractors have finalized local coverage determinations (LCDs) that will govern the provision of skin substitute grafts/cellular and tissue-based products to Medicare Part B beneficiaries when used for the treatment of diabetic foot ulcers and venous leg ulcers. On April 11, 2025, CMS announced implementation of these finalized LCDs would be delayed until January 1, 2026.
APMA formally endorses HR 657, The VA Continuing Professional Education Modernization Act, sponsored by Rep. Julia Brownley (D-CA). The bill would give Continuing Medical Education allowances for VA podiatrists and other health-care clinicians.
On April 1, the DME MACs provided guidance that clarifies replacement of compression garments used to treat lymphedema.
As a direct result of APMA and its coalition partners' advocacy efforts, House Energy & Commerce Chair Rep. Brett Guthrie (R-KY) and Rep. Brittany Pettersen (D-CO) introduced the bipartisan HR 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, which includes a technical fix to the MATE Act.
Last month, APMA hosted a successful Legislative Conference and Capitol Hill Day with nearly 100 podiatrists participating and advocating for the profession.
APMA is working closely with the Rhode Island Podiatric Medical Association (RIPMA) to defeat proposed legislation, H6088, which would permit a nurse to perform routine foot care and other related foot and ankle services in home settings with no podiatric physician supervision.
APMA is once again partnering with BFMV on its annual Physician Call Coverage Survey. Each year, BFMV surveys physicians to collect comprehensive call coverage burden and compensation data.
Following a call for comment period from the community of interest, CPME has adopted the revised CPME 720, Standards and Requirements for Approval of Continuing Education Providers in Podiatric Medicine, and CPME 730, Procedures for Approval of Continuing Education Providers in Podiatric Medicine.
On Sunday, Barry Block, DPM, JD, was awarded APMA’s highest honor, the Distinguished Service Citation. This award is given in recognition of outstanding sustained accomplishments on the national level in scientific, professional, or civic endeavors.
The 2025 APMA House of Delegates convened in Washington, DC, on Saturday morning. The house is the governing and legislative body of the organization with representatives from each of APMA’s 53 component associations.
In her first state of the association address to the House of Delegates, APMA CEO and Executive Director Meghan McClelland, MBA, outlined her vision for the association and moving podiatry into the future.